EQ
Equillium, Inc.
There isn't enough reported data to score EQ yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
EQ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
EQ's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
EQ PE Valuation
EQ has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
EQ Forward outlook
There aren't enough analyst estimates for EQ to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
EQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.20 | +$0.42 |
| Q2 2026 | -$0.22 | +$0.34 |
| Q1 2026 | -$0.34 | +$0.05 |
| Q4 2025 | -$0.52 | -$0.29 |
| Q3 2025 | -$0.62 | -$0.49 |
| Q2 2025 | -$0.56 | -$0.32 |
| Q1 2025 | -$0.39 | -$0.04 |
| Q4 2024 | -$0.23 | +$0.15 |
EQ is still losing money, but far less than before: $0.20 per share over the past year, against $2.35 at its worst in late 2022.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.83 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over EQ on earnings quality, reporting a profit while its opponent remains loss making.
EQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $4.4M | -52% |
| Q3 2024 | $12.2M | +37% |
| Q2 2024 | $13.9M | +52% |
| Q1 2024 | $10.7M | +20% |
LLY has the stronger quarterly revenue trend. Revenue is down 52% for EQ versus up 39% for LLY.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -107% | -72 points |
| Q3 2024 | -5.6% | +35 points |
| Q2 2024 | -0.7% | +39 points |
| Q1 2024 | -26% | +20 points |
| Q4 2023 | -35% | N/A |
| Q3 2023 | -41% | N/A |
| Q2 2023 | -39% | N/A |
| Q1 2023 | -46% | N/A |
EQ's operating margin was −107% last quarter, down 72 points from the same quarter a year ago, near the bottom of its range since 2023.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
EQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.8M | +$4.6M |
| Q2 2026 | -$4.2M | -$1.2M |
| Q1 2026 | -$4.3M | +$3.9M |
| Q4 2025 | -$3.2M | +$126K |
| Q3 2025 | -$8.4M | -$774K |
| Q2 2025 | -$3M | -551% |
| Q1 2025 | -$8.2M | +$646K |
| Q4 2024 | -$3.3M | +$2.4M |
EQ has burned cash in almost every quarter: −$15M over the past year, against −$23M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over EQ on cash generation, producing positive trailing cash flow while its opponent burns cash.
EQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +118K shares |
| 1 year | +71% | +46.6M shares |
| 3 years | +221% | +77M shares |
| 5 years | +281% | +82.5M shares |
| Available history | +544% | +94.5M shares |
EQ has 112M diluted shares, up 71% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over EQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
EQ Net Leverage
EQ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
EQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.6 | Neutral |
| Stochastic | 15.7 | Oversold |
EQ's weekly RSI is 37 (neutral) and its Stochastic is 16 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
EQ PE vs Healthcare Sector
EQ has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
EQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.39 | 5% below |
| 20 week MA | $1.98 | 33% below |
| 50 week MA | $1.94 | 32% below |
| 100 week MA | $1.38 | 4.3% below |
| 200 week MA | $1.19 | 11% above |
EQ has fallen below most of its moving averages, though it's still 11% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over EQ on trend strength, trading above more of its moving averages.
EQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.03 | $4.66 | +16% |
| 2021 | $4.66 | $4.49 | -3.6% |
| 2022 | $4.49 | $0.89 | -80% |
| 2023 | $0.89 | $0.72 | -19% |
| 2024 | $0.72 | $0.69 | -4.2% |
| 2025 | $0.69 | $1.50 | +117% |
| 2026 YTD | $1.50 | $1.32 | -12% |
EQ's yearly returns have swung widely, from +117% in 2025 to −80% in 2022. It's down 12% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over EQ on returns for 2026, with the stronger performance.